How the Different Weight Loss Medication Classes Work
Published October 13, 2026
You agreed to discuss medication with your doctor, and now the conversation has turned to "classes." GLP-1s, combination drugs, older generics, the categories blur together, and every article seems to assume you already know the landscape. You don't need a pharmacology degree. You need a plain map of how these medications differ in what they target in the body, how they're prescribed, and what questions to ask.
Weight loss medications fall into a few distinct classes based on their mechanism, what biological pathway they act on. The largest and most discussed class today is the GLP-1 receptor agonists, which mimic a gut hormone that regulates appetite and slows stomach emptying. Then there are older, generic appetite suppressants that work primarily on brain chemistry, and combination medications that pair an established drug with a newer one to hit multiple pathways at once. There are also medications originally developed for other conditions, diabetes, depression, seizures, that are sometimes prescribed off-label for weight. No single class is "better" across the board; the differences come down to how each works, how a clinician monitors it, and what side effects require attention. All of them sit inside physician-supervised protocols. A licensed clinician reviews your health history, labs, and risk factors before deciding whether any medication is appropriate.
The Main Classes, Side by Side
The clearest way to understand the options is to group them by what they actually do in the body. The pattern across the platforms we reviewed is consistent: telehealth programs start with a medical evaluation, then a clinician selects, or declines, a medication class based on your metabolic profile and history.
| Class | How It Works | Examples | Prescribing Context |
|---|---|---|---|
| GLP-1 receptor agonists | Mimic the GLP-1 hormone; slow gastric emptying, increase satiety signaling | Semaglutide, tirzepatide (dual GLP-1/GIP) | Weight management and type 2 diabetes; titrated under supervision |
| Older appetite suppressants | Act on norepinephrine, dopamine, or serotonin pathways to reduce hunger signals | Phentermine, naltrexone-bupropion combinations | Short-term or longer-term use, depending on the specific drug |
| Combination therapies | Pair a GLP-1 with another agent, or blend two older drugs with different mechanisms | Phentermine-topiramate, naltrexone-bupropion | Target multiple pathways; require cardio and metabolic screening |
| Off-label repurposed drugs | Originally approved for other conditions; weight effect observed secondarily | Metformin, topiramate, bupropion | Used when primary indication aligns with metabolic picture |
GLP-1s dominate the telehealth conversation because they represent the first class designed around gut-brain signaling rather than simple appetite suppression. But "newer" does not mean "universally appropriate." The older drugs have decades of safety data, cost less in many cases, and remain legitimate options when a clinician judges them suitable. The prescribing decision is individualized, that is the entire point of the medical evaluation step.
Why the Prescribing Process Looks Different for Each Class
If you've started a telehealth intake, you've noticed that the questionnaire asks things that feel unrelated to appetite: gallbladder history, thyroid conditions, pancreatitis, kidney function. That is because each medication class carries a different monitoring profile. A GLP-1 requires screening for medullary thyroid carcinoma risk and pancreatitis history. Phentermine, a stimulant-class appetite suppressant, requires a cardiovascular review and is not for people with uncontrolled hypertension or heart disease. The intake form is doing triage across classes, not just collecting your weight goal.
The prescribing workflow in physician-supervised programs follows a sequence. First, a licensed clinician reviews your health history and labs. Second, they rule out contraindications specific to the class they're considering. Third, they select a starting medication and a monitoring plan. Fourth, they schedule follow-ups at intervals that vary by class, more frequent for GLP-1 dose adjustments, less so for a stable older drug. The full telehealth weight loss process matters here because the class choice is never a self-service decision. No legitimate platform lets you pick a medication from a menu. The clinician decides, and they must document why.
Side Effect Profiles Are Not Vague Warnings
The medication classes differ most visibly in what they feel like. GLP-1s commonly cause nausea, constipation, and early fullness, effects that stem directly from slowed gastric emptying. Older stimulant-class drugs can cause dry mouth, insomnia, and elevated heart rate. Combination drugs blend both profiles, which is why clinicians often start at a low dose and adjust carefully. The NIH's overview of prescription weight management medications documents these side effect patterns in detail, and any prescribing clinician is obligated to explain them before you start.
None of this means one class is inherently riskier than another. It means the risk profile differs, and the supervision differs accordingly. A medication that slows your gut requires attention to hydration and dietary composition. A medication that raises heart rate requires blood pressure monitoring. The supervision framing is fixed: these are not over-the-counter supplements, and every class requires a prescription after a medical evaluation. You can compare how platforms structure that evaluation in our breakdown of the best telehealth weight loss platforms, but the class decision itself always comes from a clinician, not from a comparison chart.
Related reading
FAQ
What is the main difference between GLP-1s and older appetite suppressants?
GLP-1s work through gut-brain hormone signaling that slows digestion and increases fullness, while older appetite suppressants primarily act on brain chemistry to reduce hunger signals. They also carry different monitoring requirements, GLP-1s involve gastrointestinal and thyroid screening, while stimulant-class drugs require cardiovascular review.
Can I choose which medication class I want from a telehealth platform?
No. Licensed platforms require a medical evaluation, and the prescribing clinician selects a class, or decides against medication entirely, based on your health history, labs, and risk factors. No legitimate program lets you self-select a drug from a menu.
Are older weight loss medications obsolete?
No. Drugs like phentermine and certain combination therapies remain in active clinical use because they have extensive safety data and a different mechanism than GLP-1s. The right choice depends on an individual's metabolic profile and contraindications, not on how recently the drug was approved.
The classes differ in mechanism, monitoring, side effects, and prescribing context. Understanding those differences equips you to ask better questions at your first medical evaluation, including why a clinician recommends one class over another, and what monitoring that choice requires.
This article is educational content, not medical advice, and is not a substitute for a consultation with a licensed clinician. Prescription treatments require a medical evaluation, and every telehealth platform mentioned here requires one before prescribing anything. Never start, stop, or change a medication without talking to your doctor.